Catalyst Pharmaceuticals, Inc. (CPRX)
24.45
+0.01
(+0.04%)
USD |
NASDAQ |
Feb 09, 16:00
24.43
-0.02
(-0.08%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 3.005B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 624.59M |
| United Therapeutics Corp. | 20.37B |
| Supernus Pharmaceuticals, Inc. | 2.942B |
| Zoetis, Inc. | 56.10B |
| Krystal Biotech, Inc. | 7.905B |
Market Cap Related Metrics
| PE Ratio | 14.27 |
| PS Ratio | 5.369 |
| PEG Ratio | 0.3086 |
| Price to Book Value | 3.266 |
| Price to Free Cash Flow | 13.24 |
| Price | 24.45 |
| Earnings Yield | 7.01% |
| PEGY Ratio | 0.3086 |
| Operating PE Ratio | 12.00 |
| Normalized PE Ratio | 14.47 |